St. Nikolaus-Stiftshospital GmbH

The Gelenkzentrum Mittelrhein at St. Nikolaus-Stiftshospital is conducting innovative research on advanced cell‑based therapies for knee cartilage repair, testing the safety of BP CC 001, an umbilical cord‑derived mesenchymal stem cell suspension applied to a collagen support matrix.

• Safety assessment of umbilical cord‑derived MSC therapy for knee cartilage lesions
• Evaluation of a collagen scaffold as a delivery platform for regenerative cells

These studies aim to improve therapeutic techniques and equipment for managing cartilage defects, offering new options for patients with joint injuries.

In the field of musculoskeletal health, the center is comparing the mid‑term outcomes of autologous minced cartilage implantation (AMCI) with matrix‑associated autologous chondrocyte implantation (M‑ACI) for large full‑thickness knee cartilage defects, using functional scores such as the KOOS to gauge effectiveness.

• Non‑inferiority trial of minced cartilage versus M‑ACI for large knee lesions
• Assessment of patient‑reported outcomes over a two‑year follow‑up

The research supports the development of less invasive surgical options and strives to enhance quality of life for individuals suffering from severe cartilage damage.